Stereotactic body radiotherapy (SBRT) showed good local control and survival for limited metastatic/progressive cancers.

Patients with noninfectious intermediate, posterior, or panuveitis requiring immunosuppressive therapy are less likely to ...

What happens when seeking emotional fix becomes an industry? This investigation shows how therapy culture—replacing social reform, political action, and community care—has encouraged emotional ...

In triple-negative breast cancer, initially immune-enriched tumors with residual disease after neoadjuvant therapy may be ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

Young female patients had a mean baseline EF of 58.3 compared with 75 for older male patients. Additionally, emotional function scores varied by disease type. When divided by cancer type and sex, the ...

Trial met primary endpoint achieving statistically significant improvement in disease activity, with 67.1% of patients ...

Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...

The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...

Among patients with resected stage 3B to 4 melanoma, postsurgical treatment with Opdivo (nivolumab) was associated with a ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care ...

EVERSANA  to provide integrated commercialization services, enhancing launch readiness and market entry for differentiated ...